EFFECT OF FACE-TO-FACE AND VIRTUAL REALITY-BASED SALUTOGENESIS NURSING CARE IN PATIENTS WITH DEMENTIA
SM-VR-DEMENTIA
THE EFFECT OF SALUTOGENESIS MODEL-BASED NURSING CARE DELIVERED FACE-TO-FACE AND VIA VIRTUAL REALITY ON SENSE OF COHERENCE AND QUALITY OF LIFE IN PATIENTS WITH DEMENTIA
1 other identifier
interventional
73
1 country
1
Brief Summary
The purpose of this clinical study is to examine the effects of nursing care based on the Salutogenesis Model on the sense of coherence (meaningfulness, comprehensibility, and manageability) and quality of life of people living with dementia. The study will also evaluate whether delivering this nursing care face-to-face or through virtual reality leads to similar or different benefits, and whether these benefits are maintained over time. The main questions this study aims to answer are: Does face-to-face nursing care based on the Salutogenesis Model help people living with dementia strengthen their sense of coherence, cope better with daily life, and improve their quality of life? Does delivering the same nursing care using virtual reality lead to similar or different effects on sense of coherence and quality of life compared to face-to-face care? Do the positive effects of this nursing care continue after the intervention has ended? Researchers will compare three groups to answer these questions: a group receiving face-to-face nursing care based on the Salutogenesis Model, a group receiving the same nursing care using virtual reality, and a control group receiving usual care. Participants will take part in the study over a period of several months. During the study, participants will be asked to: Take part in nursing care sessions once a week for eight weeks Complete questionnaires that assess sense of coherence and quality of life Complete these questionnaires at the start of the study, after the eight-week nursing care program is completed (mid-term follow-up), and approximately three months after the interventions have ended (final follow-up) These assessments aim to evaluate both the short-term effects of the nursing care and whether these effects are sustained over the longer term. The results of this study are expected to contribute to the development of more supportive and innovative nursing care approaches for people living with dementia and to provide evidence on the use of virtual reality as a supportive tool in nursing care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2026
CompletedFirst Submitted
Initial submission to the registry
September 8, 2026
CompletedFirst Posted
Study publicly available on registry
September 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2026
CompletedSeptember 14, 2026
September 1, 2026
4 months
September 8, 2026
September 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Sense of Coherence
Sense of coherence will be assessed using the Sense of Coherence Scale (SOC-13), which evaluates the components of meaningfulness, comprehensibility, and manageability.
Baseline, after 8 weeks (post-intervention), and 3 months after the intervention
Secondary Outcomes (1)
Quality of Life (WHOQOL-BREF)
Baseline, after 8 weeks (post-intervention), and 3 months after the intervention
Study Arms (3)
Face-to-Face Salutogenesis Model-Based Nursing Care
EXPERIMENTALParticipants in this arm will receive face-to-face nursing care based on the Salutogenesis Model. The intervention will be delivered once a week for eight weeks, with each session lasting approximately 40-60 minutes. The nursing care will be structured to strengthen sense of coherence (meaningfulness, comprehensibility, and manageability) and to improve quality of life.
Virtual Reality-Supported Salutogenesis Model-Based Nursing Care
EXPERIMENTALParticipants in this arm will receive Salutogenesis Model-based nursing care supported by virtual reality headsets. The content of the intervention will be the same as the face-to-face nursing care and will be delivered once a week for eight weeks, with each session lasting approximately 40-60 minutes. The nursing care will aim to strengthen sense of coherence and improve quality of life, while virtual reality will be used as a supportive tool for delivering selected components of the intervention.
Usual Care (Control Group)
NO INTERVENTIONParticipants in this arm will continue to receive usual care during the study period and will not receive any additional structured nursing intervention related to the study.
Interventions
Nursing care based on the Salutogenesis Model delivered face-to-face once a week for eight weeks, with each session lasting approximately 40-60 minutes. The intervention focuses on strengthening sense of coherence by supporting meaningfulness, comprehensibility, and manageability, and aims to improve participants' quality of life through structured, person-centered nursing care.
Nursing care based on the Salutogenesis Model will be delivered using virtual reality headsets. The intervention will be provided once a week for eight weeks, with each session lasting approximately 40-60 minutes. The content of the intervention will be the same as that used in the face-to-face nursing care and will aim to strengthen sense of coherence and improve quality of life. Virtual reality headsets will be used as a supportive tool to deliver selected components of the nursing care in an immersive digital environment.
Eligibility Criteria
You may qualify if:
- Individuals aged 18 years and older.
- Individuals who are able to read and write.
- Individuals with a Standardized Mini-Mental Test (SMMT) score between 11 and 23, indicating mild to moderate dementia.
- Individuals without severe speech or language impairments that would limit communication.
- Individuals with non-progressive or clinically stable dementia, defined as cognitive symptoms that do not show marked deterioration over time.
- Individuals who have provided written informed consent, or whose legal representative has provided written informed consent.
- Individuals who are able to participate in the intervention sessions using virtual reality headsets independently or with the support of a caregiver.
You may not qualify if:
- Inability to complete assessments due to severe psychotic symptoms (e.g., hallucinations, paranoid thoughts) or uncontrolled behavioral symptoms such as aggression or severe agitation.
- Presence of progressive neurological diseases that impair motor and cognitive functions, such as Parkinson's disease or Huntington's disease.
- A Standardized Mini-Mental Test (SMMT) score below 10.
- Being older than 80 years of age.
- Absence of a caregiver.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Niğde/Bor
Niğde, Bor, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
HANDAN ZİNCİR, PhD
Erciyes University, Faculty of Health Sciences, Department of Public Health Nursing
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Masking Description Group allocation will be performed by an independent researcher to minimize allocation bias. While the investigator conducts the intervention sessions, the statistical analysis will be carried out by an independent analysis team who will be blinded to group assignments. All data will be coded, and the analysts will have access only to anonymized datasets, ensuring that group identity is not known during the analysis process.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Candidate
Study Record Dates
First Submitted
September 8, 2026
First Posted
September 14, 2026
Study Start
May 15, 2026
Primary Completion
September 15, 2026
Study Completion
September 15, 2026
Last Updated
September 14, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical considerations, the sensitive nature of the study population, and privacy concerns.